Post by eleva

Join Eleva at the Drug Discovery Europe in Berlin on June 15-16! As the complexity of emerging drug targets continues to increase, the ability to produce challenging biologics remains a key bottleneck in the field. Eleva’s moss-based expression platform enables the production of complex proteins that are difficult or impossible to develop using conventional systems. Interested in learning more? Connect with our Director Lead Discovery Dr. Timo Johannssen on-site to discuss how moss-based expression can support your next drug discovery program. #DrugDiscovery #DrugDevelopment #NextGenBiologics #NextLevelMedicine